Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bladder Cancer
Clinical trial register · France

Bladder Cancer Trials in France, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9714 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:18 UTC
9714
Studies in scope
all four open statuses
6038
Recruiting now
open to new participants
1027
Lead sponsors
across recruiting studies
Top sites
Lille 6 Bordeaux 5 Angers 4 Grenoble 4 Brest 3

Bladder Cancer trials in France

17 of 9714 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Institut Cancerologie de l'Ouest
Phase 1
24
Saint-Herblain
2027-01
Recruiting
Poitiers University Hospital
Not applicable
2,600
Angers, Grenoble, Le Coudray, Lille, Lyon, Marseille, Mont-de-Marsan, Nantes
2026-06-29
Recruiting
Merck Sharp & Dohme LLC
Phase 3
590
Brest, Rennes
2026-04-23
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
120
Dijon, Montpellier, Rennes, Saint-Herblain, Lille, Villeurbanne, Rouen, Avignon
2026-03-04
Recruiting
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
NCT07222488Bladder Cancer, Urinary Bladder Neoplasms
Merck Sharp & Dohme LLC
Phase 1/2
45
Villejuif
2025-12-09
Recruiting
Daiichi Sankyo
Phase 2/3
630
Angers, Bordeaux, Brest, Calais, Cedex 10, Créteil, Grenoble, La Chaussée-Saint-Victor
2025-09-26
Recruiting
University Hospital, Strasbourg, France
Observational
100
Strasbourg
2024-09-02
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Toulouse, Angers, Lille, Paris, Villejuif
2024-03-28
Recruiting
Hopital Foch
Not applicable
66
Suresnes
2023-12-14
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Bordeaux, Clermont-Ferrand, Grenoble, Limoges, Lyon, Nantes, Nîmes, Orléans
2023-03-23
Recruiting
Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence
NCT05415631Bladder Cancer, Cystoscopy, Artificial Intelligence
Centre Hospitalier Universitaire, Amiens
Observational
500
Amiens
2022-05-13
Recruiting
Bio Clinical Collection of Urothelial Carcinoma
NCT04970472Urothelial Carcinoma, Bladder Cancer
University Hospital, Toulouse
Observational
1,000
Toulouse
2021-11-16
Recruiting
Centre Hospitalier Universitaire, Amiens
Observational
500
Amiens
2021-08-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Marseille, Besançon, Brest, Toulouse, Limoges, La Tronche, Orléans, Lille
2021-04-21
Active, closed
UNICANCER
Phase 3
517
Angers, Bordeaux, Clermont-Ferrand, Ermont, Grenoble, Hyères, Le Kremlin-Bicêtre, Lille
2019-01-17
Active, closed
UNICANCER
Phase 2
79
Bordeaux, Clermont-Ferrand, Dijon, Lille, Montpellier, Mougins, Nice, Paris
2018-12-14
Rows per page Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-france/condition/bladder-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,714 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 17 of those studies listing the condition Bladder Cancer.

How many Bladder Cancer trials are recruiting in France?

11 of the 17 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bladder Cancer), 17 studies
PhaseStudiesRecruitingShare
Observational4423.5%
Phase 34123.5%
Not applicable3317.6%
Phase 1/23217.6%
Phase 1105.9%
Phase 2105.9%
Phase 2/3115.9%

Most active sponsors

Lead sponsors with the most studies (Bladder Cancer)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC53
Centre Hospitalier Universitaire, Amiens22
UNICANCER20
Daiichi Sankyo11
Hopital Foch11
Institut Cancerologie de l'Ouest10
Institut du Cancer de Montpellier - Val d'Aurelle11
Janssen Research & Development, LLC10
Poitiers University Hospital11
University Hospital, Strasbourg, France11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.